No recent analyst price targets found for SNCE.
Latest News for SNCE
Science 37 Launches Dedicated Pediatrics Department to Expand Access to Specialized Clinical Research for Children and Families
MORRISVILLE, N.C., March 17, 2026 (GLOBE NEWSWIRE) -- Science 37 , the leader in expanding patient access to clinical trials, today announced the formal launch of its dedicated Pediatrics Department , reinforcing the company's commitment to advancing pediatric research by reducing the logistical and emotional burden placed on families.
Science 37 Appoints Kelly Johnston McKee as VP of Strategy & Transformation
Kelly McKee to help shape Science 37's future patient experience, driving growth through modernized trials, innovation, and cross-team collaboration.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SNCE.
U.S. House Trading
No House trades found for SNCE.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.